Reprogramming Metabolism of Macrophages as a Target for Kidney Dysfunction Treatment in Autoimmune Diseases

Feng Tian1, Hui Chen1,2, Jianmin Zhang1,2

  • 1Department of Immunology, CAMS Key Laboratory T Cell and Cancer Immunotherapy, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, State Key Laboratory of Medical Molecular Biology, Beijing 100005, China.

Insights

Targeting macrophage metabolism offers a novel therapeutic strategy for autoimmune kidney disease. Understanding metabolic changes in immune cells can prevent and treat kidney damage, improving patient outcomes.

Area of Science:

  • Immunology
  • Nephrology
  • Metabolic pathways

Background:

  • Chronic kidney disease (CKD) is a severe complication of autoimmune diseases, causing significant health and economic burdens.
  • Immune cell dysfunction drives autoimmune diseases, with kidneys being particularly vulnerable due to their close interaction with immune cells.
  • Recent research highlights the critical role of immune cell metabolism in disease development.

Purpose of the Study:

  • To review the metabolic characteristics of macrophages in autoimmune kidney injury.
  • To summarize metabolites that regulate macrophage function in this context.
  • To explore targeting macrophage metabolism as a therapeutic approach for autoimmune kidney disease.

Main Methods:

  • Literature review focusing on cellular metabolism and immune responses in kidney disease.
  • Analysis of macrophage metabolic profiles during autoimmune-induced renal injury.
  • Synthesis of current understanding of metabolite-mediated macrophage regulation.

Main Results:

  • Macrophages play a dual role in kidney injury repair, with over-activation potentially leading to functional loss.
  • Specific metabolic alterations in macrophages are associated with the progression of autoimmune kidney disease.
  • Key metabolites influencing macrophage function in renal injury have been identified.

Conclusions:

  • Modulating macrophage metabolism presents a promising new avenue for treating autoimmune kidney diseases.
  • Targeting cellular metabolism offers a potential strategy to mitigate kidney damage and improve therapeutic outcomes.
  • Further research into macrophage metabolic pathways could lead to novel preventative and treatment strategies.